Status:

COMPLETED

Impact of Aerobika OPEP in Improving Small Airway Parameters in COPD

Lead Sponsor:

National University of Malaysia

Conditions:

COPD

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

Research Background Chronic obstructive pulmonary disease (COPD) is a progressive chronic lung disease that makes breathing difficult with mucus build-up in the inflamed airway and lungs hyperinflatio...

Detailed Description

IOS is a simple, non-invasive method requiring only passive patient cooperation without special manoeuvre for evaluation of lung function through the measurement of both airway resistance and airway r...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age 40 years or older
  • COPD diagnosed according to the GOLD guidelines: GOLD 2 - GOLD 4
  • Stable COPD patients with mucus hyperproduction: coughed and brought up sputum "several days a week" (\>2 days a week) or "almost every day" in the month prior to the study
  • Patients who can perform IOS
  • Patients who can perform spirometry
  • Patients who can perform 6MWT
  • Exclusion Criteria:
  • COPD diagnosed according to the GOLD guidelines: GOLD 1
  • Diagnosis of other chronic lung diseases: Asthma, Asthma-COPD Overlap, Interstitial Lung Disease, Bronchiectasis, Lung Cancer
  • Patients with contraindication for spirometry: recent cardiac complications, major surgery, severe advanced respiratory disease, or those with cognitively or neurologically impairment
  • Patients not recommended for OPEP: neuromuscular weakness, recent facial, oral or skull surgery or trauma, recent oesophageal surgery, active haemoptysis, acute sinusitis, untreated pneumothorax, known or suspected tympanic membrane rupture or other middle ear pathology, overt right-sided heart failure
  • Patients with contraindication for 6 minute walking test
  • Patient unable or unwilling to give informed consent
  • Change of inhaler during study period

Exclusion

    Key Trial Info

    Start Date :

    July 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2023

    Estimated Enrollment :

    53 Patients enrolled

    Trial Details

    Trial ID

    NCT05420740

    Start Date

    July 1 2022

    End Date

    June 1 2023

    Last Update

    November 14 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National University of Malaysia

    Kuala Lumpur, Kuala Lumpur, Malaysia, 56000